eSensor Respiratory Viral Panel Receives FDA Clearance

E-SENSOR XT-8 SYSTEM for use with eSensor Respiratory Virus Panel by GenMark Diagnostics
E-SENSOR XT-8 SYSTEM for use with eSensor Respiratory Virus Panel by GenMark Diagnostics

GenMark Diagnostics announced that it has received clearance from the FDA for its eSensor Respiratory Virus Panel (RVP) for use on its XT-8 system, intended to simultaneously detect and differentiate 14 clinically relevant viruses from patients with influenza-like illness.

The eSensor RVP test delivers co-infection detection, distinguishing Rhinovirus from Enteroviruses and identifying clinically relevant Adenoviruses. The eSensor RVP test enables laboratories to report patient results with rapid processing and minimal hands-on time.

GenMark currently markets four tests that are FDA cleared: Respiratory Viral Panel, Cystic Fibrosis Genotyping Test, Warfarin Sensitivity Test, and Thrombophilia Risk Test.

For more information call (800) 373-6767 or visit www.genmarkdx.com.